Target intelligence / Profile preview

Radiographic Contrast Enhancement via High Atomic Number Iodine

Molecular classification
Contrast Agent, Inorganic Compound
01

Overview

Radiographic contrast enhancement using high atomic number iodine refers to the use of iodine-containing compounds as contrast agents in medical imaging, particularly X-ray and computed tomography (CT) scans. Iodine is chosen for its high atomic number (Z = 53), which provides strong attenuation of X-rays, thereby enhancing the visibility of blood vessels, organs, and pathological structures during radiographic procedures. The effectiveness of iodine as a contrast agent is due to its k-shell binding energy (k-edge) at 33.2 keV, which closely matches the average energy range used in diagnostic radiography. Most clinical iodinated contrast agents are based on a tri-iodinated benzene ring structure. They are administered by various routes depending on the imaging requirement, primarily for blood vessels, organs, and tumors or abnormal tissue masses. Nonionic formulations have reduced incidence of side effects compared to ionic forms but may be more expensive. Nephrotoxicity remains a concern especially in patients with pre-existing kidney dysfunction; nanoparticulate formulations are being explored for improved safety profiles and targeted delivery.

02

Mechanism of action

Photoelectric absorption enhancement at k-edge (33.2 keV) of iodine, leading to increased X-ray attenuation and improved image contrast.

03

Biological functions

Diagnostic imaging enhancementX-ray attenuation
04

Disease associations

Diagnosis of various diseases including cancer, cardiovascular disease, and infections
05

Safety considerations

Allergic reactions (anaphylaxis, angioedema)Nephrotoxicity (Contrast-Induced Nephropathy - CIN)Adverse reactions to iodinated mediaExacerbation of myasthenia gravis symptoms
06

Interacting drugs

Iodinated contrast media (e.g., Iohexol, Iopamidol, Iopromide)

Beyond the preview

Go deeper on Radiographic Contrast Enhancement via High Atomic Number Iodine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Radiographic Contrast Enhancement via High Atomic Number Iodine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call